Bank of New York Mellon’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $762M | Sell |
|
|||||
|
2025
Q2 | $702M | Sell |
|
|||||
|
2025
Q1 | $756M | Sell |
|
|||||
|
2024
Q4 | $1.13B | Buy |
|
|||||
|
2024
Q3 | $975M | Sell |
|
|||||
|
2024
Q2 | $1.08B | Sell |
|
|||||
|
2024
Q1 | $1.3B | Sell |
|
|||||
|
2023
Q4 | $1.17B | Sell |
|
|||||
|
2023
Q3 | $1.27B | Sell |
|
|||||
|
2023
Q2 | $1.32B | Sell |
|
|||||
|
2023
Q1 | $1.24B | Sell |
|
|||||
|
2022
Q4 | $848M | Buy |
|
|||||
|
2022
Q3 | $429M | Buy |
|
|||||
|
2022
Q2 | $375M | Buy |
|
|||||
|
2022
Q1 | $245M | Buy |
|
|||||
|
2021
Q4 | $262M | Sell |
|
|||||
|
2021
Q3 | $243M | Sell |
|
|||||
|
2021
Q2 | $261M | Buy |
|
|||||
|
2021
Q1 | $177M | Buy |
|
|||||
|
2020
Q4 | $176M | Buy |
|
|||||
|
2020
Q3 | $169M | Buy |
|
|||||
|
2020
Q2 | $138M | Sell |
|
|||||
|
2020
Q1 | $127M | Sell |
|
|||||
|
2019
Q4 | $126M | Buy |
|
|||||
|
2019
Q3 | $116M | Sell |
|
|||||
|
2019
Q2 | $104M | Buy |
|
|||||
|
2019
Q1 | $90.8M | Buy |
|
|||||
|
2018
Q4 | $80.1M | Sell |
|
|||||
|
2018
Q3 | $105M | Sell |
|
|||||
|
2018
Q2 | $85.2M | Sell |
|
|||||
|
2018
Q1 | $76M | Sell |
|
|||||
|
2017
Q4 | $85.2M | Sell |
|
|||||
|
2017
Q3 | $83.5M | Buy |
|
|||||
|
2017
Q2 | $80.7M | Buy |
|
|||||
|
2017
Q1 | $68.7M | Buy |
|
|||||
|
2016
Q4 | $69.1M | Buy |
|
|||||
|
2016
Q3 | $60M | Buy |
|
|||||
|
2016
Q2 | $60.3M | Sell |
|
|||||
|
2016
Q1 | $58.5M | Buy |
|
|||||
|
2015
Q4 | $50.8M | Sell |
|
|||||
|
2015
Q3 | $49.5M | Buy |
|
|||||
|
2015
Q2 | $48.6M | Buy |
|
|||||
|
2015
Q1 | $47.2M | Buy |
|
|||||
|
2014
Q4 | $40.9M | Sell |
|
|||||
|
2014
Q3 | $36.6M | Sell |
|
|||||
|
2014
Q2 | $35.3M | Buy |
|
|||||
|
2014
Q1 | $34.2M | Sell |
|
|||||
|
2013
Q4 | $51.9M | Sell |
|
|||||
|
2013
Q3 | $44.2M | Sell |
|
|||||
|
2013
Q2 | $45.8M | Buy |
|